Sinntaxis
Lund, SE · 1 known investors
Find your way into Sinntaxis
Sign up to find every way you can get introduced to Sinntaxis
- Your email: who you already know at Sinntaxis, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Sinntaxis team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Sinntaxis is a pharmaceutical company developing mGluR5 negative allosteric modulators as a drug therapy to restore brain function and support recovery after stroke and brain injury. Spun out of Lund University, it runs a preclinical discovery platform for stroke recovery research and licensed IP on this treatment approach.
Founders & leadership
TW

Tadeusz WielochFounder & CEO
Investors · 1
Frequently asked questions
- What does Sinntaxis do?
- Sinntaxis is a pharmaceutical company developing mGluR5 negative allosteric modulators as a drug therapy to restore brain function and support recovery after stroke and brain injury. Spun out of Lund University, it runs a preclinical discovery platform for stroke recovery research and licensed IP on this treatment approach.
- Who founded Sinntaxis?
- Sinntaxis was founded by Tadeusz Wieloch.
- Who are Sinntaxis's investors?
- Sinntaxis's investors include LU Innovation.
- Where is Sinntaxis headquartered?
- Sinntaxis is headquartered in Lund, SE.